{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:00:58Z","timestamp":1767837658583,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Mae Stone Goode Foundation"},{"name":"Pilot Grant Department of Obstetrics and Gynecology University of Rochester, Rochester, NY"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.12.067","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T07:48:29Z","timestamp":1579247309000},"page":"1581-1585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Women who received varicella vaccine versus natural infection have different long-term T cell immunity but similar antibody levels"],"prefix":"10.1016","volume":"38","author":[{"given":"Ellen","family":"Tourtelot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Quataert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Christopher","family":"Glantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Perlis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowrishankar","family":"Muthukrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Mosmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.12.067_b0005","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.12.067_b0010","unstructured":"Marin M, Guris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices CfDC, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports\/Centers for Disease Control. 2007;56:1-40."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.12.067_b0015","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1086\/529448","article-title":"Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella","volume":"197","author":"Breuer","year":"2008","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.12.067_b0020","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/522123","article-title":"Humoral and cellular immunity to varicella-zoster virus: an overview","volume":"197","author":"Arvin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.067_b0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/infdis\/154.3.422","article-title":"Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection","volume":"154","author":"Arvin","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.067_b0030","doi-asserted-by":"crossref","first-page":"e3789","DOI":"10.1371\/journal.pone.0003789","article-title":"Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka","volume":"3","author":"Malavige","year":"2008","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.12.067_b0035","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1386-6532(10)70002-0","article-title":"Advances in the understanding of the pathogenesis and epidemiology of herpes zoster","volume":"48","author":"Gershon","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2019.12.067_b0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.12.067_b0045","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1128\/CVI.05130-11","article-title":"Comparative study of the standard fluorescent antibody to membrane antigen (FAMA) assay and a flow cytometry-adapted FAMA assay to assess immunity to varicella-zoster virus","volume":"18","author":"Lafer","year":"2011","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2019.12.067_b0050","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/CVI.00818-13","article-title":"Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians","volume":"21","author":"Ogunjimi","year":"2014","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2019.12.067_b0055","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/nprot.2006.268","article-title":"Intracellular cytokine optimization and standard operating procedure","volume":"1","author":"Lamoreaux","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2019.12.067_b0060","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cyto.a.22445","article-title":"SWIFT-scalable clustering for automated identification of rare cell populations in large, high-dimensional flow cytometry datasets, Part 2: Biological evaluation","volume":"85","author":"Mosmann","year":"2014","journal-title":"Cytometry A"},{"key":"10.1016\/j.vaccine.2019.12.067_b0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/375828","article-title":"Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination","volume":"188","author":"Frey","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.067_b0070","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.vaccine.2017.03.054","article-title":"Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection","volume":"35","author":"Duncan","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.067_b0075","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.vaccine.2019.12.067_b0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/74715","article-title":"Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children","volume":"6","author":"Krause","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.12.067_b0085","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1086\/651199","article-title":"Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses","volume":"201","author":"Weinberg","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.067_b0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2249.2008.03785.x","article-title":"Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals","volume":"155","author":"Chidrawar","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2019.12.067_b0095","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.4049\/jimmunol.169.4.1984","article-title":"Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals","volume":"169","author":"Khan","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.12.067_b0100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/315347","article-title":"Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression","volume":"181","author":"Asanuma","year":"2000","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:41:29Z","timestamp":1759401689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20300037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X20300037"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Women who received varicella vaccine versus natural infection have different long-term T cell immunity but similar antibody levels","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}